Buels_2012_Handb.Exp.Pharmacol_208_317

Reference

Title : Muscarinic receptor antagonists: effects on pulmonary function - Buels_2012_Handb.Exp.Pharmacol_208_317
Author(s) : Buels KS , Fryer AD
Ref : Handbook of Experimental Pharmacology , :317 , 2012
Abstract :

In healthy lungs, muscarinic receptors control smooth muscle tone, mucus secretion, vasodilation, and inflammation. In chronic obstructive pulmonary disease (COPD) and asthma, cholinergic mechanisms contribute to increased bronchoconstriction and mucus secretion that limit airflow. This chapter reviews neuronal and nonneuronal sources of acetylcholine in the lung and the expression and role of M(1), M(2), and M(3) muscarinic receptor subtypes in lung physiology. It also discusses the evidence for and against the role of parasympathetic nerves in asthma, and the current use and therapeutic potential of muscarinic receptor antagonists in COPD and asthma.

PubMedSearch : Buels_2012_Handb.Exp.Pharmacol_208_317
PubMedID: 22222705

Related information

Citations formats

Buels KS, Fryer AD (2012)
Muscarinic receptor antagonists: effects on pulmonary function
Handbook of Experimental Pharmacology :317

Buels KS, Fryer AD (2012)
Handbook of Experimental Pharmacology :317